BackConatus Pharmaceuticals Overview

Conatus Pharmaceuticals Accounts Payable

Latest accounts payable for CNAT: $0.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$0.00

Peer trimmed avg / median

Loading

Conatus Pharmaceuticals Accounts Payable History

Loading

Conatus Pharmaceuticals vs. peers: Accounts Payable Comparison

Loading

Conatus Pharmaceuticals Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Conatus Pharmaceuticals (CNAT) FAQ

Conatus Pharmaceuticals (CNAT) currently reports a accounts payable of $0 as of March 2020. In the prior-year period, the figure was $0. Use the charts on this page to explore Conatus Pharmaceuticals's accounts payable history and peer comparisons.

Conatus Pharmaceuticals's accounts payable changed from $0 to $0 (period ending March 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Conatus Pharmaceuticals reported $0 in accounts payable as of March 2020. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Conatus Pharmaceuticals, and consider following CNAT for alerts when major investors trade the stock.

Conatus Pharmaceuticals is classified in the Healthcare sector. On accounts payable, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CNAT with unrelated industries.